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Abstract

Results

Discussion

First line pharmacologic treatments for adult patients with
Obsessive Compulsive Disorder (OCD) involve selective
serotonin/norepinephrine reuptake inhibitors (SSRI/SNRIs). These
drug classes often fail to deliver timely relief of symptoms as well
as maintain longevity of symptom recurrence. This research
analyzed the use of ketamine in adult patients suffering with OCD
for the purposes of more efficacious management of symptoms.
Although ketamine demonstrated a timelier relief of symptoms in
some small clinical studies, its effects were ultimately unable to be
sustained long term. Additionally, a wide range of adverse effects
including dissociation, and rebound symptoms were observed. As
a result, large scale longitudinal studies are needed to further
evaluate all possible adverse effects in order to contract for patient
safety.

The evidence collected by each of the studies
demonstrated statistically significant improvement in
symptoms due to ketamine based on the Yale-Brown
Obsessive Compulsive Scale (Y-BOCS). There was also
evidence that ketamine allowed for better engagement in
psychotherapy, which in turn allowed for clinically
significant relief of symptoms. There was clinical evidence
that demonstrated the effects of ketamine could be
prolonged by pharmaceutical methods, but the length of
prolongation varied wildly among participants. Ultimately,
the clinical effects of ketamine varied significantly. The
side effects of ketamine ranged from mild dissociation, to
distortion in reality with rebound worsening of symptoms
hours to days post-infusion. Additionally, there are no large
scale randomized controlled trials to date involving the use
of ketamine for the treatment of adult patients with OCD.

A majority of the studies showed clinically and statistically
significant relief of symptoms. There were two randomized
controlled trials (RCTs) whose study designs appeared to be the
most reliable, and contributed significantly to the small body of
literature that currently exists on the topic. It should be noted
ketamine has discernible sedative effects that are difficult to mask.
As a result, it is difficult to perform truly double blinded studies and
remains a significant obstacle for future study designs.
Furthermore, there was a lack of longitudinal studies resulting in
the long term effects of ketamine remaining widely unknown. More
prospective RCTs need to be performed to determine the true
efficacy of ketamine in this patient population. Lastly, a majority of
the studies had small sample sizes resulting in a subsequently low
power and low confidence interval. While ketamine and some novel
NMDA receptors such as memantine did show promise in acutely
decreasing symptoms, the level of variability of benefits between
patients still remains a primary concern. Primarily we have learned:
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OCD is a mental illness that causes a patient to suffer with
debilitating obsessions and compulsions resulting in a negative
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Methods
A literature search was completed through PubMed and Academic
Search Ultimate on September 2018 and November 2018,
respectively. A total of seven articles were selected based on their
relevance to the research question, publication date, study design,
outcomes, and results.
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Ketamine has an acute onset of action which plays a role in the
immediate relief of symptoms demonstrated.
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Other NMDA receptors antagonists also seem to have an antiobsessional effect on patients.
NMDA agents have shown potential for increasing compliance and
participation in CBT sessions. This allows patients to develop longterm non-pharmacologic coping mechanisms.

Conclusion
It is difficult to assess the efficacy of ketamine primarily due to its
sedative properties. There is a high likelihood that the reported
reduction in symptomatology post-infusion may have been a result
of such elements. Additionally, there was a vast range of clinical
benefits between studies regardless of similarities in patient
populations. While the current evidence is not strong enough to
recommend ketamine for clinical practice at this time, the antiobsessional effects of ketamine and NMDA receptor antagonists
does show potential. Future research is warranted to establish the
parameters of ketamine’s efficacy in order to better contract for
patient safety. With larger clinical RCTs, a stronger argument can
be made for future modification of guidelines for patient care in this
population.

